Delivery Order SPE2DB22D2007-SPE2DB25FJ3VJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units, valued at $17,849.85 under a Firm Fixed Price contract type. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive set-aside delivery against the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for OJJAARA 100 mg tablets in quantities of 30, with a contract ceiling value of $17,912.32. This firm fixed-price delivery order, set to be completed by August 14, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency has awarded a delivery order valued at $17,849.85 to AmerisourceBergen Drug Corp for the supply of Ojjaara 200 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a $17,849.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ojjaara 200 mg tablets in quantities of 30 units. The contract, which represents a child award under AmerisourceBergen's larger IDC with DLA, is scheduled for completion by August 25, 2025. The award was made on a competitive basis with no set-aside designation, and the pharmaceutical products will be delivered to the company's corporate...
- This is a $17,849.85 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through July 28, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle. This...
- This is a $17,849.85 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency. The contract is for the supply of OJJAARA 200 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through July 23, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and U.S....
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $17,894.90 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is set to be completed by July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OJJAARA 200 MG TABLET UU 30S, with a ceiling value of $17,849.85 and a period of performance through February 21, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award was issued on July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $39,727.67 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract was issued on August 2, 2025, with an ultimate completion date of the same day, indicating a rapid fulfillment requirement. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3VJDelivery Order
The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units, with a completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that supports pharmaceutical supply needs for military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical procurement through its extensive contract portfolio with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the type of individual pharmaceutical transactions executed under the broader global pharmaceutical support vehicle, which enables flexible sourcing of medications and medical supplies to meet military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 8/11/25 |